Annals of Hepatology (Jul 2020)

Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?

  • Francesco Giuseppe Foschi,
  • Marco Domenicali,
  • Pierluigi Giacomoni,
  • Anna Chiara Dall’Aglio,
  • Fabio Conti,
  • Alberto Borghi,
  • Vittoria Bevilacqua,
  • Lucia Napoli,
  • Federica Mirici,
  • Alessandro Cucchetti,
  • Giorgio Ercolani,
  • Andrea Casadei Gardini,
  • Stefano Bellentani,
  • Amalia Gastaldelli,
  • Mauro Giuffrè,
  • Claudio Tiribelli,
  • Giorgio Bedogni

Journal volume & issue
Vol. 19, no. 4
pp. 380 – 387

Abstract

Read online

Introduction and objectives: Surrogate biomarkers of liver fibrosis developed in tertiary care are increasingly used in general populations. We evaluated the association between liver stiffness (LS) and five continuous (AST/ALT, APRI, Forns Index, FIB-4, GGT) and two discrete biomarkers (BARD, BAAT) in a general population. Patients and methods: 636 (29%) of the 2159 citizens of the Bagnacavallo Study had LS measured by transient elastography. Using linear regression with univariate multiple imputation, we evaluated the association of LS with the above biomarkers in the total sample of 2159 citizens. Results: The mean change of LS between the 5th and 95th internal percentile of any continuous biomarker was ≤1 kPa. The mean change of LS between scores 0 and 3 of BARD and scores 0 and ≥3 of BAAT was >1 kPa but of doubtful clinical relevance. Conclusion: We found a modest association between LS and seven biomarkers of liver fibrosis in a general population.

Keywords